Balance Sheets - USD ($)		Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash		$ 224,474	$ 20
Prepaid expenses		494,844
Due from related party		28,462
Marketable securities held in trust account		194,767,885	0
Total current assets		195,515,665	20
Non-current assets:
Deferred offering costs associated with the proposed public offering			842,520
Total non-current assets			842,520
Total Assets		195,515,665	842,540
Current liabilities:
Accounts payable		8,185
Accrued expenses		307,966	49,174
Accrued offering costs		279,678	690,626
Promissory note – related party			126,894
Deferred underwriting commissions		6,641,250
Total current liabilities		7,237,079	866,694
Total Liabilities		7,237,079	866,964
Commitments and Contingencies (Note 7)
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized, 18,975,000 and -0- shares subject to redemption issued and outstanding as of December 31, 2022 and 2021, respectively		194,767,885
Shareholders' Deficit:
Preference shares, $0.0001 par value, 5,000,000 shares authorized; none issued and outstanding		0	0
Additional paid-in capital			24,526
Accumulated deficit		(6,489,773)	(49,154)
Total Shareholders' Deficit		(6,489,299)	(24,154)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit		195,515,665	842,540
Common Class A [Member]
Shareholders' Deficit:
Ordinary shares		0	0
Common Class B [Member]
Shareholders' Deficit:
Ordinary shares	[1],[2]	$ 474	$ 474

[1] In January 2022, the Company effected a share capitalization for an additional 431,250 Class B ordinary shares, resulting in 4,743,750 Class B ordinary shares outstanding. All share and per-share amounts have been retroactively restated to reflect the share capitalization.

[2] Includes up to 618,750 shares of Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 6) as of December 31, 2021. The underwriter exercised the over-allotment option in full on January 18, 2022.